切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2018, Vol. 04 ›› Issue (02) : 205 -210. doi: 10.3877/cma.j.issn.2096-1537.2018.02.019

所属专题: 文献

综述

肺移植围术期处理
桑岭1, 刘晓青1, 黎毅敏1,()   
  1. 1. 510120 广州医科大学附属第一医院 广州呼吸疾病研究所重症医学科
  • 收稿日期:2017-05-16 出版日期:2018-05-28
  • 通信作者: 黎毅敏

Perioperative management of lung transplantation

Ling Sang1, Xiaoqing Liu1, Yimin Li1,()   

  1. 1. Department of Critical Care Medicine, the 1st Affiliated Hospital of Guangzhou Medical University Guangzhou Institute of Respiratory Disease, Guangzhou 510120, China
  • Received:2017-05-16 Published:2018-05-28
  • Corresponding author: Yimin Li
  • About author:
    Corresponding author: Li Yimin, Email:
引用本文:

桑岭, 刘晓青, 黎毅敏. 肺移植围术期处理[J/OL]. 中华重症医学电子杂志, 2018, 04(02): 205-210.

Ling Sang, Xiaoqing Liu, Yimin Li. Perioperative management of lung transplantation[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2018, 04(02): 205-210.

肺移植术(LTX)是治疗终末期肺疾病的一种有益选择。由于我国供体肺紧缺以及大量终末期肺疾病患者没能及时进行肺移植评估,导致这些患者需要在重症医学科(ICU)内行生命支持的同时进行LTX等待及评估;而且这些患者的术后并发症也较多。这样ICU医生对肺移植受体围术期评估和支持能力面临着巨大的挑战。本文就在ICU内LTX受体的围术期管理,包括术前评估,术后并发症以及体外膜氧合(ECMO)技术的应用,根据国外的文献结合本中心的经验进行综述。

Lung transplantation (LTX) is an optimal therapy for end-stage of lung disease. Because of the shortage of donor lung and the failure of LTX assessment timely in patients with end-stage lung disease, a large number of LTX recipients have to receive the life supports and assessments of LTX in Intensive Care Unit (ICU). These recipients always have more postoperative complications. In this way, it is a great challenge for ICU physicians to deliver life support and assessment for the LTX recipients during the perioperation. In this review we will discuss the perioperative managements in ICU, including preoperative evaluation, postoperation complications management and the utility of extracorporeal membrane oxygenation (ECMO), based on the foreign literatures and the experience of our center.

[1]
Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis [J]. N Engl J Med, 1986, 314(18): 1140-1145.
[2]
Yusen RD,Edwards LB,Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report—2014, focus theme: retransplantation [J]. J Heart Lung Transplant, 2014, 33(10): 1009-1024.
[3]
黄剑伟,龙小毛. 肺移植供肺保护研究进展[J/CD].实用器官移植电子杂志, 2014, 2(2): 117-119.
[4]
陈静瑜. 肺移植供体肺的维护及获取 [J]. 武汉大学学报(医学版), 2016, 37(4): 540-542.
[5]
Yusen RD,Christie JD,Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report—2013, focus theme: age [J]. J Heart Lung Transplant, 2013, 32(10): 965-978.
[6]
Jones RM,Enfield KB,Mehrad B, et al. Prevalence of obstructive coronary artery disease in patients undergoing lung transplantation: case series and review of the literature [J]. Catheter Cardiovasc Interv, 2014, 84(1): 1-6.
[7]
McKellar SH,Bowen ME,Baird BC, et al. Lung transplantation following coronary artery bypass surgery-improved outcomes following single-lung transplant [J]. J Heart Lung Transplan, 2016, 35(11): 1289-1294.
[8]
Chaikriangkrai K,Jyothula S,Jhun HY, et al. Impact of preoperative coronary artery disease on cardiovascular events following lung transplantation [J]. J Heart Lung Transplant, 2016, 35(1): 115-121.
[9]
Koprivanac M,Budev MM,Yun JJ, et al. How important is coronary artery disease when considering lung transplant candidates? [J]. J Heart Lung Transplant, 2016, 35(12): 1453-1461.
[10]
Andersen KH,Schultz HH,Nyholm B, et al. Pulmonary hypertension as a risk factor of mortality after lung transplantation [J]. Clin Transplant, 2016, 30(4): 357-364.
[11]
Christie JD,Sager JS,Kimmel SE, et al. Impact of primary graft failure on outcomes following lung transplantation [J]. Chest, 2005, 127(1): 161-165.
[12]
Lee JC,Christie JD,Keshavjee S. Primary graft dysfunction: definition, risk factors, short- and long-term outcomes [J]. Semin Respir Crit Care Med, 2010, 31(2): 161-171.
[13]
López-Aguilar J,Piacentini E,Villagrá A, et al. Contributions of vascular flow and pulmonary capillary pressure to ventilator-induced lung injury [J]. Crit Care Med, 2006, 34(4): 1106-1112.
[14]
Pérez-Terán P,Roca O,Rodríguez-Palomares J, et al. Prospective validation of right ventricular role in primary graft dysfunction after lung transplantation [J]. Eur Respir J, 2016, 48(6): 1732-1742.
[15]
Shah PR,Boisen ML,Winger DG, et al. Extracorporeal support during bilateral sequential lung transplantation in patients with pulmonary hypertension: risk factors and outcomes [J]. J Cardiothorac Vasc Anesth, 2017, 31(2): 418-425.
[16]
Balcı MK,Arı E,Vayvada M, et al. Assessment of pulmonary hypertension in lung transplantation candidates: correlation of Doppler echocardiography with right heart catheterization [J]. Transplant Proc, 2016, 48(8): 2797-2802.
[17]
Mainz JG,Hentschel J,Schien C, et al. Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation [J]. J Cyst Fibros, 2012, 11(2): 158-161.
[18]
Hirche TO,Knoop C,Hebestreit H, et al. Practical guidelines: lung transplantation in patients with cystic fibrosis [J]. Pulm Med, 2014, 2014: 621342.
[19]
Gottlieb J,Mattner F,Weissbrodt H, et al. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis [J]. Respir Med, 2009, 103(5): 743-749.
[20]
Courtwright AM,Salomon S,Lehmann LS, et al. The association between mood, anxiety and adjustment disorders and hospitalization following lung transplantation [J]. Gen Hosp Psychiatry, 2016, 41(1): 1-5.
[21]
Jha SR,Hannu MK,Gore K, et al. Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation [J]. J Heart Lung Transplant, 2016, 35(9): 1092-1100.
[22]
Kelm DJ,Bonnes SL,Jensen MD, et al. Pre-transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation [J]. Clin Transplant, 2016, 30(3): 247-255.
[23]
Upala S,Panichsillapakit T,Wijarnpreecha K, et al. Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and meta-analysis [J]. Transpl Int, 2016, 29(3): 285-296.
[24]
Sharma NS,Hartwig MG,Jr HD. Extracorporeal membrane oxygenation in the pre and post lung transplant period [J]. Ann Transl Med, 2017, 5(4): 74
[25]
Egan TM,Edwards LB. Effect of the lung allocation score on lung transplantation in the United States [J]. J Heart Lung Transplant, 2016, 35(4): 433-9.
[26]
Hoopes CW,Kukreja J,Golden J, et al. Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation [J]. J Thorac Cardiovasc Surg, 2013, 145(3): 862-867.
[27]
Nazarnia S,Subramaniam K. Pro: veno-arterial extracorporeal membrane oxygenation (ECMO) should be used routinely for bilateral lung transplantation [J]. J Cardiothorac Vasc Anesth, 2017, 31(4): 1505-1508.
[28]
Yu WS,Paik HC,Haam SJ, et al. Transition to routine use of venoarterial extracorporeal oxygenation during lung transplantation could improve early outcomes [J]. J Thorac Dis, 2016, 8(7): 1712-1720.
[29]
Ius F,Sommer W,Tudorache I, et al. Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: indications and midterm results [J]. J Heart Lung Transplant, 2016, 35(1): 49-58.
[30]
Glassman LR,Keenan RJ,Fabrizio MC, et al. Extracorporeal membrane oxygenation as an adjunct treatment for primary graft failure in adult lung transplant recipients [J]. J Thorac Cardiovasc Surg, 1995, 110(3): 723-726.
[31]
Zenati M,Pham SM,Keenan RJ, et al. Extracorporeal membrane oxygenation for lung transplant recipients with primary severe donor lung dysfunction [J]. Transpl Int, 1996, 9(3): 227-230.
[32]
Pereszlenyi A,Lang G,Steltzer H, et al. Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension [J]. Eur J Cardiothorac Surg, 2002, 21(5): 858-863.
[33]
Salman J,Ius F,Sommer W, et al. Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertension [J]. Eur J Cardiothorac Surg, 2017, 52(1): 163-170.
[34]
Lam CP,Chow MP. HLA antibodies in multiple transfused patients [J]. Zhonghua Yi Xue Za Zhi (Taipei), 1992, 50(6): 439-442.
[35]
Hayes D Jr,Preston TJ,Kirkby S, et al. Human leukocyte antigen sensitization in lung transplant candidates supported by extracorporeal membrane oxygenation [J]. Am J Respir Crit Care Med, 2013, 188(5): 627-628.
[36]
Ong LP,Sachdeva A,Ramesh BC, et al. Lung transplant with cardiopulmonary bypass: impact of blood transfusion on rejection, function, and late mortality [J]. Ann Thorac Surg, 2016, 101(2): 512-519.
[37]
Ong LP,Thompson E,Sachdeva A, et al. Allogeneic blood transfusion in bilateral lung transplantation: impact on early function and mortality [J]. Eur J Cardiothorac Surg, 2016, 49(2): 668-674.
[38]
Hayes D Jr,Tumin D,Yates AR, et al. Transfusion with packed red blood cells while awaiting lung transplantation is associated with reduced survival after lung transplantation [J]. Clin Transplant, 2016, 30(12): 1545-1551.
[39]
Montefusco CM,Veith FJ. Lung transplantation [J]. Surg Clin North Am, 1986, 66(3): 503-515.
[40]
Lee JC,Christie JD. Primary graft dysfunction [J]. Clin Chest Med, 2011, 32(2): 279-293.
[41]
Bonser RS,Taylor R,Collett D, et al. Cardiothoracic Advisory Group to NHS Blood and Transplant and the Association of Lung Transplant Physicians (UK). Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry [J]. Lancet, 2012, 380(9843): 747-755.
[42]
Diamond JM,Lee JC,Kawut SM, et al, Lung Transplant Outcomes Group. Clinical risk factors for primary graft dysfunction after lung transplantation [J]. Am J Respir Crit Care Med, 2013, 187(5): 527-534.
[43]
Christie JD,Carby M,Bag R, et al. ISHLT Working Group on primary lung graft dysfunction. Report of the ISHLT Working Group on primary lung graft dysfunction part Ⅱ: definition. A consensus statement of the international society for heart and lung transplantation [J]. J Heart Lung Transplant, 2005, 24(10): 1454-1459.
[44]
Júnior AJE,Campos W E D,Medeiros C R, et al. Lung transplantation [J]. Einstein (Sao Paulo), 2015, 13(2): 297-304.
[45]
Geltner C,Lass-Flörl C. Invasive pulmonary Aspergillosis in organ transplants - Focus on lung transplants [J]. Respir Investig, 2016, 54(2): 76-84.
[46]
Weigt SS,Elashoff RM,Huang C, et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome [J]. Am J Transplant, 2009, 9(8): 1903-1911.
[47]
Bhaskaran A,Mumtaz K,Husain S. Anti-aspergillus prophylaxis in lung transplantation: A systematic review and Meta-analysis [J]. Curr Infect Dis Rep, 2013, 15(6): 514-525.
[48]
Neoh CF,Snell GI,Kotsimbos T, et al. Antifungal prophylaxis in lung transplantation—A World-wide Survey [J]. Am J Transplant, 2011, 11(2): 361-366.
[49]
Patterson TF,Denning DW,Fishman JA, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America [J]. Clin Infect Dis, 2016, 63(4): 1-60.
[50]
Campos S,Caramori M,Teixeira R, et al. Bacterial and fungal pneumonias after lung transplantation [J]. Transplant Proc, 2008, 40(3): 822-824.
[51]
Schaenman JM. Is universal antifungal prophylaxis mandatory in lung transplant patients? [J]. Curr Opin Infect Dis, 2013, 26(4): 317-325.
[52]
Pilarczyk K,Haake N,Heckmann J, et al. Is universal antifungal prophylaxis mandatory in adults after lung transplantation? A review and meta-analysis of observational studies [J]. Clin Transplant 2016, 30(12): 1522-1531.
[53]
Schaenman JM. Is universal antifungal prophylaxis mandatory in lung transplant patients? [J]. Curr Opin Infect Dis, 2013, 26(4): 317-325.
[54]
Johansson I,Mårtensson G,Nyström U, et al. Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients [J]. BMC Infect Dis, 2013, 13(1): 582-592.
[55]
Santos CA,Brennan DC,Yusen RD, et al. Incidence, risk factors and outcomes of delayed-onset cytomegalovirus disease in a large retrospective cohort of lung transplant recipients [J]. Transplantation, 2015, 99(8): 1658-1666.
[56]
Paraskeva M,Bailey M,Levvey BJ, et al. Cytomegalovirus replication within the lung allograft is associated with bronchiolitis obliterans syndrome [J]. Am J Transplant, 2011, 11(10): 2190-2196.
[57]
Christie JD,Edwards LB,Kucheryavaya AY, et al. The registry of the international society of heart and lung transplantation: 29th adult lung and heart-lung transplant report-2012 [J]. J Heart Lung Transplant, 2012, 31(10): 1073-1086.
[58]
Estenne M,Maurer JR,Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria [J]. J Heart Lung Transplant, 2001, 21(3): 297-310.
[59]
Snell GI,Westall GP,Levvey BJ, et al. A randomized, double-blind, placebo-controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation [J]. Am J Transplant, 2014, 14(5): 1191-1198.
[60]
崔向丽,宫丽丽,胡滨, 等. 肺移植术后的免疫抑制剂应用进展 [J]. 国际呼吸杂志, 2016, 36(3): 228-232.
[61]
Chen L,Gilstrap D,Cox CE. Mechanical ventilator discontinuation process [J]. Clin Chest Med, 2016, 37(4): 693-699.
[62]
Felten ML,Moyer JD,Dreyfus JF, et al. Foch Lung Transplant Group. Immediate postoperative extubation in bilateral lung transplantation: predictive factors and outcomes [J]. Br J Anaesth, 2016, 116(6): 847-854.
[63]
Van De Wauwer C,Van Raemdonck D, et al. Risk factors for airway complications within the first year after lung transplantation [J]. Eur J Cardiothorac Surg, 2007, 31(4): 703-710.
[64]
Mughal MM,Gildea TR,Murthy S, et al. Short-term deployment of self-expanding metallic stents facilitates healing of bronchial dehiscence [J]. Am J Respir Crit Care Med, 2005, 172(6): 768-771.
[65]
D′Angelo AM,Chan EG,Hayanga JW, et al. Atrial arrhythmias after lung transplantation: incidence and risk factors in 652 lung transplant recipients [J]. J Thorac Cardiovasc Surg, 2016, 152(3): 901-909.
[66]
Fan J,Zhou K,Li S, et al. Incidence, risk factors and prognosis of postoperative atrial arrhythmias after lung transplantation: a systematic review and meta-analysis [J]. Interact Cardiovasc Thorac Surg, 2016, 23(5): 790-799.
[67]
Hackman KL,Snell GI,Bach LA. Poor glycemic control is associated with decreased survival in lung transplant recipients [J]. Transplantation, 2017, 101(9): 2200-2206.
[1] 轩晨昊, 许红阳. 降钙素原对双肺移植患者术后痰培养阳性的预测价值研究[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(03): 211-214.
[2] 梁靓, 谭征, 黄婷, 高跃, 章坚, 夏杰. 新生儿先天性膈疝术后呼吸支持相关危险因素分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(01): 9-17.
[3] 黄莹, 李璇, 刘梦杨, 彭桂林, 徐鑫, 韦兵, 杨超. 靶向联合治疗双肺移植术后KRAS和BRAF基因双突变晚期肺腺癌一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 298-301.
[4] 中华医学会器官移植学分会. 中国肺移植气道并发症临床诊疗指南(2024版)[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 266-274.
[5] 寇宛婷, 蔡英华, 周海琴, 吴琼. 肺移植术后谵妄影响因素的范围综述[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 251-256.
[6] 汪子涵, 张瑾, 肖飞, 梁朝阳. 常温体外肺灌注技术治疗肺缺血再灌注损伤的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(01): 48-54.
[7] 夏慧, 廖慧, 戴艳萍, 吴俊萍, 杨诚, 李建雄, 刘存东. 医护合作——快速康复模式在单孔腹腔镜上尿路重建围手术期的应用研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 266-270.
[8] 邓世君, 刘晓青, 刘权兴. 信息化管理在肺癌围手术期中的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 466-468.
[9] 袁丹艳, 鲁静, 王丽娇, 岳彩迎, 范博士, 王蓉蓉. 肺康复训练在MIE围术期的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 131-133.
[10] 奚琼, 芮祖琴. ECMO在成人呼吸衰竭治疗及转运中的应用进展[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(06): 899-902.
[11] 赵浩, 尚峰, 程玮涛, 徐跃峤, 齐猛, 蒋丽丹, 陈文劲, 王宁, 曲鑫. 神经外科围术期瞳孔改变的相关因素分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(03): 147-150.
[12] 黄淑萍, 龚蓓, 申铁梅, 杨丹莉, 陈秀梅, 李国琪, 李星, 麦爱欢, 钟冰, 广东省护士协会心血管疾病护理分会, 南方心血管护理联盟. 心房颤动患者介入手术围术期护理专家共识[J/OL]. 中华介入放射学电子杂志, 2024, 12(01): 1-9.
[13] 李子健, 王锐, 钟云鹏, 张迪轩, 梁韵娟, 杨超, 何建行, 李树本. 自体肺移植术在胸部恶性肿瘤中的临床应用[J/OL]. 中华胸部外科电子杂志, 2024, 11(03): 193-200.
[14] 李宁, 刘言, 林慧庆. 肺移植供肺缺血再灌注损伤的机制及预防[J/OL]. 中华胸部外科电子杂志, 2023, 10(04): 247-256.
[15] 詹维强, 李梦蝶, 涂玉玲, 郭艳, 芦乙滨, 史新格, 许明. 早期CRRT联合VA-ECMO治疗难治性心源性休克的临床效果[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 260-268.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?